856
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Lowering of IOP by Echothiophate Iodide in Pseudophakic Eyes with Glaucoma

, , , , &
Pages 698-702 | Received 22 Jan 2010, Accepted 21 Mar 2010, Published online: 30 Jul 2010

REFERENCES

  • Stark WJ, Goyal RK, Awad O, et al. The safety and efficacy of combined phacoemulsification and trabeculectomy with releasable sutures. Br J Ophthalmol. 2006;90:146–149.
  • Christakis C, Mangouritsas N. Comparative studies of the pressure-lowering effect of timolol and phospholine iodide. Klin Monatsbl Augenheilkd. 1981;179:197–200.
  • Reichert RW, Shields MB. Intraocular pressure response to the replacement of pilocarpine or carbachol with echothiophate. Graefe’s Arch Clin Exp Ophthalmol. 1991;229:252–253.
  • Schwartzenberg GW, Buys YM. Efficacy of brimonidine 0.2% as adjunctive therapy for patients with glaucoma inadequately controlled with otherwise maximal medical therapy. Ophthalmology. 1999;106:1616–1620.
  • Patelska B, Greenfield DS, Liebmann JM, et al. Latanoprost for uncontrolled glaucoma in a compassionate case protocol. Am J Ophthalmol. 1997;124:279–286.
  • Harris LS. Dose-response analysis of echothiophate iodide. Arch Ophthalmol. 1971;86:502–505.
  • Harris LS. Comparison of pilocarpine and echothiophate iodide in open angle glaucoma. Ann Ophthalmol. 1972;4:736–743.
  • Pape LG, Forbes M. Retinal detachment and miotic therapy. Am J Ophthalmol. 1978;85:558–566.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.